These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ovarian hyperstimulation in polycystic ovary syndrome during therapy with leuprolide acetate. Walmer DK; Haney AF; Dodson WC Fertil Steril; 1989 Nov; 52(5):858-9. PubMed ID: 2509254 [TBL] [Abstract][Full Text] [Related]
4. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation. Venturini PL; Remorgida V; Anserini P; De Cecco L Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583 [TBL] [Abstract][Full Text] [Related]
5. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction. Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938 [TBL] [Abstract][Full Text] [Related]
6. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Homburg R; Eshel A; Kilborn J; Adams J; Jacobs HS Hum Reprod; 1990 Jan; 5(1):32-5. PubMed ID: 2108981 [TBL] [Abstract][Full Text] [Related]
7. Ovarian sensitivity to gonadotrophins in patients with PCO is unaffected by suppression of LH. Fleming R; Hamilton MP; Conaghan C; Black WP; Coutts JR Clin Endocrinol (Oxf); 1990 Jan; 32(1):33-8. PubMed ID: 2110046 [TBL] [Abstract][Full Text] [Related]
8. Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction. Filicori M; Flamigni C; Cognigni G; Dellai P; Michelacci L; Arnone R Fertil Steril; 1994 Aug; 62(2):279-85. PubMed ID: 8034073 [TBL] [Abstract][Full Text] [Related]
9. Ovulation and the polycystic ovary syndrome. Jansen RP Aust N Z J Obstet Gynaecol; 1994 Jun; 34(3):277-85. PubMed ID: 7848200 [TBL] [Abstract][Full Text] [Related]
10. A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS). Ito T; Michioka T; Kobayashi M; Narimatsu A; Yamashita S; Matsuzaki H; Kuramoto T; Numa F; Yakabe A Horm Res; 1990; 33 Suppl 2():32-4. PubMed ID: 2128879 [TBL] [Abstract][Full Text] [Related]
11. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835 [TBL] [Abstract][Full Text] [Related]
12. The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist. Gadir AA; Alnaser HM; Mowafi RS; Shaw RW Fertil Steril; 1992 Feb; 57(2):309-13. PubMed ID: 1735480 [TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730 [TBL] [Abstract][Full Text] [Related]
14. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome. Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881 [TBL] [Abstract][Full Text] [Related]
15. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease. Remorgida V; Venturini PL; Anserini P; Salerno E; de Cecco L Fertil Steril; 1991 Jan; 55(1):61-5. PubMed ID: 1898892 [TBL] [Abstract][Full Text] [Related]
16. [Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative]. Steck T; Würfel W; Witteler M; Albert P Geburtshilfe Frauenheilkd; 1991 May; 51(5):373-8. PubMed ID: 1907938 [TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients. Dale PO; Tanbo T; Haug E; Abyholm T Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931 [TBL] [Abstract][Full Text] [Related]
18. Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome. Hughes E; Collins J; Vandekerckhove P Cochrane Database Syst Rev; 2000; (2):CD000097. PubMed ID: 10796488 [TBL] [Abstract][Full Text] [Related]
19. Clinical utility of adjuvant growth hormone in the treatment of patients with polycystic ovaries undergoing in vitro fertilization. Artini PG; de Micheroux AA; Taponeco F; Cela V; D'Ambrogio G; Genazzani AR J Assist Reprod Genet; 1997 Jan; 14(1):4-7. PubMed ID: 9013300 [No Abstract] [Full Text] [Related]
20. Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Farhi J; Soule S; Jacobs HS Fertil Steril; 1995 Nov; 64(5):930-5. PubMed ID: 7589636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]